Skip to main content
Skip to main navigation menu
Skip to site footer
Open Menu
About
About the Journal
Privacy Statement
Open access policy
Contact
Current
Archives
Editorial Board
Procedure for consideration and publication of materials
Guides for authors
Cost of publication
Archive 2018-2006
Search
Login
Home
/
Archives
/
Vol. 43 No. 2 (2021): Experimental Oncology
Vol. 43 No. 2 (2021): Experimental Oncology
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-2
Published:
26.05.2023
Original contributions
RAD51-UTR haplotype genetic polymorphisms and susceptibility to breast cancer in women from Jordanian population
M.S. Al Zoubi, L.N. AL-Eitan, D.M. Rababa’h, K. Al-Batayneh, R. Farzand, G.A. Quinn, M.M. Tambuwala, H.A. Bakshi
149-154
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-2.16338
Therapeutic results of laryngeal preservation: a retrospective study
W. Ben Kridis, I. Werda, W. Mnejja, N. Toumi, I. Charfeddine, J. Daoud, A. Khanfir
168-172
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-2.16273
Expression of TLR4 and major inflammatory cytokines in patients with bladder cancer of different grade and stage
P.G. Yakovlev, O.I. Gorbach, L.I. Ostapchenko, L.V. Garmanchuk, O.V. Skachkova, N.M. Khranovska, N.V. Senchylo
142-148
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-2.16102
Co-administration of apigenin with doxorubicin enhances anti-migration and antiproliferative effects via PI3K/PTEN/AKT pathway in prostate cancer cells
A. Ayyildiz, H. Koc, K. Turkekul, S. Erdogan
125-134
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-2.16096
A variant of TP53 gene (rs 1625895, 13494g>A) is associated with neoplasm localization in patients with uterine leiomyoma
A.G. Kornatska, М.А. Flaksemberg, G.V. Chubei, О.V. Trokhymovych, Z.I. Rossokha, L.Ye. Fishchuk, N.L. Medvedieva, V.O. Vershyhora, N.G. Gorovenko
155-158
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-2.16195
5-FU resistant colorectal cancer cells possess improved invasiveness and βIII-tubulin expression
S. Akalovich, A. Portyanko, A. Pundik, A. Mezheyeuski, T. Doroshenko
111-117
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-2.16314
Expression of chemokine receptor CXCR4 in tumor cells and content of CXCL12+-fibroblasts in endometrioid carcinoma of endometrium
L.G. Buchynska, O.M. Movchan, N.P. Iurchenko
135-141
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-2.16240
Significance of BRAFV600E mutation in intra-axial brain tumor in Malaysian patients: case series and literature review
A.A. Mohamed Yusoff , S.M. Abd Radzak, S.Z.N. Mohd Khair, J.M. Abdullah
159-167
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-2.16076
In vitro modeling of tumor interclonal interactions using breast cancer cell lines
V.A. Bychkov, A.M. Pevzner, J.A. Nebova, N.N. Ermakova, M.K. Ibragimova, M.M. Tsyganov, L.S. Lyapunova, N.V. Litviakov
118-124
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-2.16142
Evaluation of response to tyrosine kinase inhibitors in renal cell carcinoma patients based on expression of miR-99b, -144, -210, -222, -302а and -377 in tumor tissue
Yu.V. Vitruk, S.L. Semko, O.A. Voylenko, M.V. Pikul, T.V. Borikun, T.V. Zadvornyi, T.M. Yalovenko, E.O. Stakhovsky, O.V. Rossylna
98-103
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-2.16383
Role of tumor/endothelial cell interactions in tumor growth and metastasis
O.N. Pyaskovskaya, D.L. Kolesnik, L.V. Garmanchouk, Yu.V. Yanish, G.I. Solyanik
104-110
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-2.16157
Short communications
Study of modifying effects of astaxanthin on cytogenetic manifestations of bystander response in human peripheral blood lymphocytes in vitro
M.A. Pilinska, O.V. Shemetun, O.О. Talan, O.B. Dibska, V.V. Talko
173-176
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-2.16301
Point of view
Predicting changes in glomerular filtration rate in patients with kidney cancer using a mathematical model
S.M. Pasichnyk, M.S. Pasichnyk, A.E. Lychkovsky, E.O. Stakhovsky, A.I. Gozhenko, S.V. Shatnyi, M.A. Pasichnyk
185-188
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-2.16214
Long-term exposure to low doses of ionizing radiation and COVID-19 pandemic: oncohematological aspects
D.F. Gluzman, M.P. Zavelevich, A.A. Philchenkov, S.V. Koval, L.N. Guslitser, V.N. Zinchenko, T.O. Bezhenar
189-192
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-2.16434
Case report
Scrotal cutaneous metastasis from rectal squamous cell carcinoma: a rare evolution into a rare tumor
V. De Giorgi, F. Venturi, F. Portelli, P. Maida, F. Scarfì, L. Trane, A. Gori, F. Silvestri, D. Massi
177-179
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-2.16284
Minireview
Systemic chemotherapeutic treatment of patients with breast cancer brain metastases
R. Liubota, R. Vereshchako, M. Anikusko, I. Liubota, G. Vakulenko
180-184
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-2.16249
Language
Українська
English
Current Issue